ZYEPTI
Live / Registered — Registered (as of 03 Aug 2021)
What this means for you
Registered since 03 Aug 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79291195
- Registration number
- 6436392
- Mark type
- Stylized text
- Filed
- 25 Feb 2020
- Published for opposition
- 18 May 2021
- Registered
- 03 Aug 2021
- Attorney of record
- Maren C. Perry
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and medical preparations and substances for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions; Vaccines; Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; Pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; Preparations, substances, reagents and agents for diagnostic and medical purposes, namely, for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions
Owner
- Lundbeck Seattle BioPharmaceuticals Inc., DE, US
- Lundbeck Seattle BioPharmaceuticals Inc., DE, US
- Lundbeck Seattle BioPharmaceuticals Inc., DE, US
- H. Lundbeck A/S, DE, US
Prosecution history
- 20 Feb 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 07 Jan 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Jan 2022 — FINAL DISPOSITION PROCESSED
- 03 Nov 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 03 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 18 May 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 May 2021 — PUBLISHED FOR OPPOSITION
- 17 May 2021 — NOTIFICATION PROCESSED BY IB
- 28 Apr 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 28 Apr 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 28 Apr 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Apr 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Mar 2021 — ASSIGNED TO LIE